miR-1297 Suppresses Osteosarcoma Proliferation and Aerobic Glycolysis by Regulating PFKFB2

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-1297 (miR-1297) is recognized as a tumor suppressor in various cancers.
• The specific role of miR-1297 in osteosarcoma (OS) development and progression remains largely uninvestigated.
• Understanding miR-1297's function in OS is crucial for identifying novel therapeutic targets.

Purpose of the Study:

• To elucidate the functional impact of miR-1297 on osteosarcoma progression.
• To investigate the underlying molecular mechanisms by which miR-1297 exerts its effects in OS.
• To explore the relationship between miR-1297, PFKFB2, and metabolic alterations in OS.

Main Methods:

• Quantitative real-time PCR and Western blotting were used to assess gene and protein expression.
• Cell proliferation, colony formation, and apoptosis assays were performed to evaluate cellular behavior.
• Bioinformatics, dual-luciferase reporter assays, and metabolic flux analysis were employed to identify and validate targets and metabolic changes.

Main Results:

• miR-1297 expression was found to be downregulated in osteosarcoma tissues and cells.
• Reduced miR-1297 expression promoted OS cell proliferation and enhanced the Warburg effect (aerobic glycolysis).
• PFKFB2 was identified as a direct target of miR-1297; its silencing inhibited proliferation and aerobic glycolysis, while its overexpression counteracted miR-1297's tumor-suppressive effects.

Conclusions:

• The miR-1297/PFKFB2 axis plays a critical role in regulating osteosarcoma cell proliferation and metabolism.
• miR-1297 functions as a tumor suppressor in OS by modulating the Warburg effect via PFKFB2.
• This study reveals a novel link between metabolic reprogramming and cancer progression, suggesting miR-1297 as a potential therapeutic target for osteosarcoma.